ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,083,098 | +0.1% | 86,321 | -4.6% | 0.01% | 0.0% |
Q2 2023 | $8,077,303 | -17.8% | 90,502 | -1.3% | 0.01% | -22.2% |
Q1 2023 | $9,831,324 | -12.2% | 91,693 | +0.0% | 0.01% | -25.0% |
Q4 2022 | $11,197,122 | +22.5% | 91,682 | +3.6% | 0.01% | +33.3% |
Q3 2022 | $9,139,000 | +14.6% | 88,497 | +3.1% | 0.01% | +12.5% |
Q2 2022 | $7,976,000 | -28.2% | 85,800 | -9.4% | 0.01% | 0.0% |
Q1 2022 | $11,108,000 | -4.1% | 94,651 | +10.0% | 0.01% | +33.3% |
Q4 2021 | $11,580,000 | -12.9% | 86,072 | +3.2% | 0.01% | -14.3% |
Q3 2021 | $13,299,000 | +35.6% | 83,434 | +11.9% | 0.01% | +40.0% |
Q2 2021 | $9,807,000 | -25.6% | 74,552 | -27.1% | 0.01% | -28.6% |
Q1 2021 | $13,183,000 | +67.6% | 102,294 | +116.9% | 0.01% | +75.0% |
Q4 2020 | $7,865,000 | – | 47,155 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 10,719,555 | $1,003,779,130 | 19.76% |
Q Global Advisors, LLC | 285,000 | $26,687 | 17.16% |
Finepoint Capital LP | 163,772 | $15,335,610 | 7.64% |
Avoro Capital Advisors LLC | 3,670,000 | $343,658,800 | 5.36% |
Spyglass Capital Management LLC | 614,618 | $57,552,830 | 4.51% |
Sofinnova Investments, Inc. | 754,032 | $70,607,556 | 4.45% |
Saturn V Capital Management LP | 112,473 | $10,531,972 | 4.41% |
DAFNA Capital Management LLC | 136,212 | $12,754,892 | 3.97% |
ARS Investment Partners, LLC | 285,918 | $26,773,362 | 3.32% |
Ghost Tree Capital, LLC | 85,000 | $7,959,400 | 2.62% |